Geng Wang
Shiyan, 442000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Retraction notice to "Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers" [Biomedicine & Pharmacotherapy 181 (2024) 117714].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 19, 2026
Case report: A case of malignant phyllodes tumor of the breast with concurrent epithelial malignancy and heterologous chondrosarcomatous differentiation.
Journal: Frontiers in oncology
Published: February 10, 2026
Dual action of pyrimidine derivatives: Targeting tamoxifen resistance in breast cancer.
Journal: Translational oncology
Published: November 13, 2024
Decoding tumor microenvironment: EMT modulation in breast cancer metastasis and therapeutic resistance, and implications of novel immune checkpoint blockers.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 14, 2024
Crystal Structure, Infrared Reflection Spectrum, and Improved Microwave Dielectric Characteristics of Ba4Sm28/3Ti18O54 Ceramics via One-Step Reaction Sintering.
Journal: Materials (Basel, Switzerland)
Published: June 19, 2024
Pyrimidine-triazole-tethered tert-butyl-piperazine-carboxylate suppresses breast cancer by targeting estrogen receptor signaling and β-catenin activation.
Journal: IUBMB life
Published: May 23, 2024
Discovery of oxazine-linked pyrimidine as an inhibitor of breast cancer growth and metastasis by abrogating NF-κB activation.
Journal: Frontiers in oncology
Published: February 24, 2024
Fabrication of nanoscale T-shaped reentrant structures and its hydrophobic analysis.
Journal: Scientific reports
Published: September 22, 2023
The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer.
Journal: Frontiers in endocrinology
Published: July 19, 2023
GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights.
Journal: Frontiers in oncology
Published: May 12, 2023
Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
Journal: Gland surgery
Published: October 25, 2022
Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Journal: Frontiers in immunology
Published: July 18, 2022
Last Updated: 09/26/2026